Commonwealth Equity Services’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,385
Closed -$14K 4023
2023
Q4
$14K Sell
1,385
-105
-7% -$998 ﹤0.01% 3840
2023
Q3
$16K Sell
1,490
-22
-1% -$265 ﹤0.01% 3748
2023
Q2
$21K Hold
1,512
﹤0.01% 3743
2023
Q1
$15 Sell
1,512
-9
-0.6% -$152 ﹤0.01% 3691
2022
Q4
$23K Sell
1,521
-33
-2% -$564 ﹤0.01% 3588
2022
Q3
$30K Sell
1,554
-592
-28% -$14.3K ﹤0.01% 3535
2022
Q2
$54K Buy
2,146
+500
+30% +$11.5K ﹤0.01% 3470
2022
Q1
$40K Sell
1,646
-16
-1% -$343 ﹤0.01% 3604
2021
Q4
$46K Sell
1,662
-30
-2% -$984 ﹤0.01% 3543
2021
Q3
$70K Buy
1,692
+84
+5% +$3.52K ﹤0.01% 3462
2021
Q2
$74K Hold
1,608
﹤0.01% 3435
2021
Q1
$88K Buy
1,608
+457
+40% +$30.3K ﹤0.01% 3286
2020
Q4
$83K Buy
1,151
+8
+0.7% +$939 ﹤0.01% 3085
2020
Q3
$225K Buy
1,143
+201
+21% +$50.6K ﹤0.01% 2612
2020
Q2
$263K Buy
942
+85
+10% +$19.8K ﹤0.01% 2375
2020
Q1
$152K Buy
+857
New +$184K ﹤0.01% 2481
2018
Q4
Sell
-796
Closed -$354K 2683
2018
Q3
$354K Sell
796
-79
-9% -$37K ﹤0.01% 2036
2018
Q2
$412K Buy
875
+114
+15% +$60.3K ﹤0.01% 1891
2018
Q1
$448K Sell
761
-4
-0.5% -$2.48K ﹤0.01% 1786
2017
Q4
$415K Buy
+765
New +$346K ﹤0.01% 1823

Other funds holding ASMB

Commonwealth Equity Services's ASMB Position: Q1 2024 in Review

Commonwealth Equity Services sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 1,385 shares — an estimated $14K sold.

Commonwealth Equity Services first reported a position in ASMB in Q4 2017 and held it in 20 quarters. The position peaked at $448K in Q1 2018. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • Commonwealth Equity Services reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,385 Assembly Biosciences shares in Q1 2024, an estimated $14K.
  • Commonwealth Equity Services first reported a position in Assembly Biosciences in Q4 2017 and held it in 20 quarters.
  • Commonwealth Equity Services's Assembly Biosciences position peaked at $448K in Q1 2018.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on Commonwealth Equity Services's 13F filing for Q1 2024, filed 29 Apr 2024.